Massachusetts cities and towns, school districts, libraries, public hospitals and other entities will be able to purchase rapid COVID-19 test kits for $5 to $26.
U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests
at 9:51 am NPR
The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus, which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.
The Food and Drug Administration gave emergency authorization to Ellume s rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older.
Ellume Limited
toggle caption Ellume Limited
Ellume, an Australian company, manufactures a 15-minute at-home test for the coronavirus, which causes COVID-19. Ellume Limited
Updated 5:30 p.m. ET
The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.
The Food and Drug Administration gave emergency authorization to Ellume s rapid test in December, after it showed 96% accuracy in a U.S. clinical study. Those trials included both adults and children of ages 2 years and older.
FDA Nod For Abbott s At-home Covid-19 Test
NORTH CHICAGO (dpa-AFX) - The U.S. Food and Drug Administration has issued a new emergency use authorization or EUA for Abbot Diagnostics Covid-19 home test.
The BinaxNOW COVID-19 Ag Card Home Test is now authorized for prescription use at home with self-collected nasal swab samples from individuals ages 15 years or older who are suspected of COVID-19 by their healthcare provider.
The test is also authorized for use with adult-collected nasal swab samples from individuals ages four years or older who are suspected of COVID-19 by their healthcare provider.
In both instances, the test can be conducted within the first seven days of symptom onset.